Treatment of steroid sensitive nephrotic syndrome

Area of Science:

• Pediatric Nephrology
• Glomerular Disorders
• Chronic Kidney Disease Management

Background:

• Childhood idiopathic nephrotic syndrome (NS) is a chronic glomerular disorder with risks of infection, thromboembolism, and malnutrition.
• Minimal change disease (MCD) accounts for over 90% of childhood NS cases, often responding to corticosteroids.
• Steroid-sensitive NS is generally benign, but relapsing courses necessitate effective management to prevent complications and minimize steroid toxicity.

Purpose of the Study:

• To outline the management goals for childhood idiopathic nephrotic syndrome (NS).
• To discuss therapeutic strategies for maintaining remission and minimizing adverse effects in children with NS.
• To review the use and associated side-effects of steroid-sparing agents in NS treatment.

Main Methods:

• Literature review of therapeutic regimens for childhood idiopathic nephrotic syndrome (NS).
• Analysis of corticosteroid efficacy in minimal change disease (MCD).
• Evaluation of steroid-sparing agents including alkylating agents, calcineurin inhibitors, and immunomodulatory drugs.

Main Results:

• Corticosteroids are effective in a majority of childhood NS cases, particularly MCD.
• Steroid-sparing agents like cyclophosphamide, cyclosporin A, and levamisole have shown variable success.
• These alternative agents are associated with specific side-effects that require careful consideration.

Conclusions:

• Effective management of childhood NS requires balancing treatment benefits against risks.
• Therapeutic strategies must address frequent relapses and minimize long-term steroid toxicity.
• Careful weighing of benefits and risks is crucial when considering steroid-sparing agents for NS treatment.